Most People Seeking a Kidney Transplant in the US Never Reach the Waitlist, Data Shows

Approximately 40% of patients referred for kidney transplantation in the United States do not progress to the national organ waitlist, according to a 2023 analysis by the United Network for Organ Sharing (UNOS). This gap highlights systemic barriers in access to life-saving care, with factors including medical ineligibility, socioeconomic challenges, and disparities in healthcare access playing key roles.

What Causes Patients to Drop Out of the Transplant Process?

Patients may fail to reach the transplant waitlist for several reasons. Medical criteria, such as severe comorbidities or poor overall health, often disqualify candidates, according to the National Kidney Foundation. Additionally, logistical hurdles—like lack of transportation, insurance coverage, or access to specialized care—can prevent individuals from completing the evaluation process. A 2022 study in the *Journal of the American Medical Association* (JAMA) found that patients from lower-income backgrounds were 2.3 times more likely to be excluded from transplant lists due to these barriers.

How Do Waitlist Inequities Affect Outcomes?

The inability to reach the waitlist disproportionately impacts marginalized groups. Data from the Organ Procurement and Transplantation Network (OPTN) shows that Black and Hispanic patients are underrepresented on transplant lists compared to their prevalence in the end-stage renal disease population. This disparity contributes to longer wait times and higher mortality rates for these groups, as reported by the Centers for Disease Control and Prevention (CDC) in 2023.

What Is Being Done to Address the Issue?

Efforts to expand access include initiatives by the Department of Health and Human Services (HHS) to streamline eligibility evaluations and increase funding for community health programs. For example, the 2021 Kidney Health Initiative—a collaboration between the National Institutes of Health (NIH) and private stakeholders—aims to reduce barriers through education and targeted outreach. However, advocates argue that more comprehensive reforms are needed to address systemic inequities.

Why Does This Matter for Public Health?

Kidney failure affects over 750,000 Americans, with transplant being the most effective treatment. The current system’s inefficiencies not only cost lives but also strain healthcare resources, as dialysis—a lifelong treatment—costs an estimated $124 billion annually, per the American Kidney Fund. Addressing waitlist access could significantly improve survival rates and reduce long-term healthcare expenditures.

For patients and families navigating this process, consulting with a nephrologist and local transplant centers is critical. Resources like the UNOS patient navigator tool and the National Kidney Disease Education Program offer guidance on eligibility and next steps.